Zhu, W., Dotson, A. L., Libal, N. L., Lapato, A. S., Bodhankar, S., Offner, H., & Alkayed, N. J. (2014). Recombinant T-cell Receptor Ligand RTL1000 Limits inflammation and Decreases Infarct Size after Experimental Ischemic Stroke in Middle-Aged Mice. Neuroscience.

Zhu, W., A. L. Dotson, N. L. Libal, A. S. Lapato, S. Bodhankar, H. Offner, und N. J. Alkayed. "Recombinant T-cell Receptor Ligand RTL1000 Limits Inflammation and Decreases Infarct Size After Experimental Ischemic Stroke in Middle-Aged Mice." Neuroscience 2014.

Zhu, W., et al. "Recombinant T-cell Receptor Ligand RTL1000 Limits Inflammation and Decreases Infarct Size After Experimental Ischemic Stroke in Middle-Aged Mice." Neuroscience 2014.